보스턴 사이언티픽 코퍼레이션
DE ˙ XTRA ˙ FR0010424135
€41.05 ↓ -0.25 (-0.61%)
2026-06-04
주가
SecurityDE:BSX / Boston Scientific Corporation
InstitutionAllstate Corp
Latest Disclosed Ownership153,970 shares
Latest Disclosed Value $ 9,661,618
Allstate Corp reports 37.29% increase in ownership of BSX / Boston Scientific Corporation

On May 11, 2026 - Allstate Corp filed a 13F-HR form disclosing ownership of 153,970 shares of Boston Scientific Corporation (DE:BSX) valued at $8,283,586 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 9, 2026 disclosing 112,146 shares of Boston Scientific Corporation. This represents a change in shares of 37.29% during the quarter. The current value of the position is $6,320,468 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F BOSTON SCIENTIFIC ORD Equity 101137107 153,970 41,824 37.29 9,662 -9.65 0.0956
2026-02-09 2025-12-31 13F BOSTON SCIENTIFIC ORD Equity 101137107 112,146 57,769 106.24 10,693 101.45 0.1461
2025-10-29 2025-09-30 13F BOSTON SCIENTIFIC ORD Equity 101137107 54,377 50,829 1,432.61 5,309 1,293.18 0.1212
2025-08-05 2025-06-30 13F BOSTON SCIENTIFIC ORD Equity 101137107 3,548 -47,785 -93.09 381 -92.64 0.0275
2025-05-14 2025-03-31 13F BOSTON SCIENTIFIC ORD Equity 101137107 51,333 7,589 17.35 5,178 32.53 0.1522
2025-02-12 2024-12-31 13F BOSTON SCIENTIFIC ORD Equity 101137107 43,744 43,744 3,907 0.1151
2024-11-14 2024-09-30 13F BOSTON SCI ENTIFIC CORP COM EQU 101137107 0 -5,779 -100.00 0 -100.00
2024-08-13 2024-06-30 13F BOSTON SCI ENTIFIC CORP COM EQU 101137107 5,779 0 0.00 445 12.66 0.0361
2024-05-10 2024-03-31 13F BOSTON SCI ENTIFIC CORP COM EQU 101137107 5,779 -159 -2.68 396 15.16 0.0281
2024-02-09 2023-12-31 13F BOSTON SCI ENTIFIC CORP COM EQU 101137107 5,938 165 2.86 343 12.83 0.0237
2023-11-13 2023-09-30 13F BOSTON SCI ENTIFIC CORP COM EQU 101137107 5,773 0 0.00 305 -2.56 0.0178
2023-08-14 2023-06-30 13F BOSTON SCI ENTIFIC CORP COM EQU 101137107 5,773 0 0.00 312 8.33 0.0199
2023-05-10 2023-03-31 13F BOSTON SCIENTIFIC EQU 101137107 5,773 -58,678 -91.04 289 -90.34 0.0215
2023-02-14 2022-12-31 13F BOSTON SCI ENTIFIC CORP COM EQU 101137107 64,451 700 1.10 2,982 20.78 0.0907
2022-11-14 2022-09-30 13F BOSTON SCI ENTIFIC CORP COM EQU 101137107 63,751 7,122 12.58 2,469 16.96 0.0711
2022-08-15 2022-06-30 13F BOSTON SCI ENTIFIC CORP COM EQU 101137107 56,629 13,615 31.65 2,111 10.81 0.0650
2022-05-16 2022-03-31 13F BOSTON SCI ENTIFIC CORP COM EQU 101137107 43,014 -1,727 -3.86 1,905 0.21 0.0509
2022-02-15 2021-12-31 13F BOSTON SCI ENTIFIC CORP COM EQU 101137107 44,741 2,847 6.80 1,901 4.57 0.0363
2021-11-15 2021-09-30 13F BOSTON SCI ENTIFIC CORP COM EQU 101137107 41,894 -3,372 -7.45 1,818 -6.10 0.0752
2021-08-16 2021-06-30 13F BOSTON SCI ENTIFIC EQU 101137107 45,266 -2,996 -6.21 1,936 3.81 0.0649
2021-05-14 2021-03-31 13F BOSTON SCIENTIFIC EQU 101137107 48,262 5,612 13.16 1,865 21.66 0.0585
2021-02-12 2020-12-31 13F BOSTON SCIENTIFIC EQU 101137107 42,650 7,139 20.10 1,533 12.97 0.0476
2020-11-13 2020-09-30 13F BOSTON SCIENTIFIC EQU 101137107 35,511 -6,076 -14.61 1,357 -7.05 0.0440
2020-08-13 2020-06-30 13F BOSTON SCIENTIFIC EQU 101137107 41,587 -11,321 -21.40 1,460 -15.41 0.0502
2020-05-15 2020-03-31 13F BOSTON SCIENTIFIC COMMON 101137107 52,908 -82,507 -60.93 1,726 -71.81 0.0676
2020-02-14 2019-12-31 13F BOSTON SCIENTIFIC COMMON 101137107 135,415 499 0.37 6,123 11.53 0.1111
2019-11-14 2019-09-30 13F BOSTON SCIENTIFIC COMMON 101137107 134,916 0 0.00 5,490 -5.33 0.0944
2019-08-14 2019-06-30 13F BOSTON SCIENTIFIC COMMON 101137107 134,916 17,069 14.48 5,799 28.21 0.1036
2019-05-20 2019-03-31 13F BOSTON SCIENTIFIC COMMON 101137107 117,847 0 0.00 4,523 8.60 0.1219
2019-02-13 2018-12-31 13F BOSTON SCIENTIFIC COMMON 101137107 117,847 117,847 4,165 0.1368
2017-11-14 2017-09-30 13F BOSTON SCIENTIFIC COMMON 101137107 0 -64,201 -100.00 0 -100.00
2017-08-14 2017-06-30 13F BOSTON SCIENTIFIC COMMON 101137107 64,201 -43,911 -40.62 1,780 -33.80 0.0946
2017-05-15 2017-03-31 13F BOSTON SCIENTIFIC COMMON 101137107 108,112 108,112 2,689 0.1629
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.